Stevanato Group S.p.A (STVN) Cash from Investing Activities (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Cash from Investing Activities of -$82.4 million for Q1 2026, down 10.81% year-over-year from -$92.4 million in Q1 2025, and up 25.0% on a QoQ basis from -$109.9 million in Q4 2025.
Stevanato Group S.p.A (STVN) has 7 years of Cash from Investing Activities data on file, last reported at -$82.4 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 10.81% year-over-year to -$82.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$316.2 million (down 5.85% YoY) and the FY2025 annual result came in at -$317.7 million, up 4.17% from the prior year.
- Cash from Investing Activities rose to -$82.4 million in Q1 2026 per STVN's latest filing, from -$109.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$43.6 million in Q3 2022 and bottomed at -$143.9 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is -$81.3 million (2022), against an average of -$84.6 million.
- The widest annual swing landed in 2023, when Cash from Investing Activities tumbled 230.4%; it then soared 63.68% in 2024.
- Tracing STVN's Cash from Investing Activities over 5 years: stood at -$70.3 million in 2022, then tumbled by 41.27% to -$99.3 million in 2023, then gained by 2.08% to -$97.2 million in 2024, then declined by 13.0% to -$109.9 million in 2025, then grew by 25.0% to -$82.4 million in 2026.
- Per Business Quant, the three latest STVN Cash from Investing Activities figures stand at -$82.4 million (Q1 2026), -$109.9 million (Q4 2025), and -$56.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -58.03 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -42.70 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -77.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | -102.90 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -131.58 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -133.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -65.10 Mn |
| 10 | Stevanato Group S.p.A | 5.73 Bn | 5.59 Bn | 88.04 Mn | -82.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -82.42 Mn |
| Mar 31, 2026 | -82.42 Mn |
| Dec 31, 2025 | -109.89 Mn |
| Dec 31, 2025 | -109.89 Mn |
| Sep 30, 2025 | -56.35 Mn |
| Sep 30, 2025 | -56.35 Mn |
| Jun 30, 2025 | -67.58 Mn |
| Jun 30, 2025 | -67.58 Mn |
| Mar 31, 2025 | -74.38 Mn |
| Mar 31, 2025 | -74.38 Mn |
| Dec 31, 2024 | -97.24 Mn |
| Dec 31, 2024 | -97.24 Mn |
| Sep 30, 2024 | -52.28 Mn |
| Sep 30, 2024 | -52.28 Mn |
| Jun 30, 2024 | -74.84 Mn |
| Jun 30, 2024 | -74.84 Mn |
| Mar 31, 2024 | -110.93 Mn |
| Mar 31, 2024 | -110.93 Mn |
| Dec 31, 2023 | -99.31 Mn |
| Dec 31, 2023 | -99.31 Mn |
| Sep 30, 2023 | -143.91 Mn |
| Sep 30, 2023 | -143.91 Mn |
| Jun 30, 2023 | -89.18 Mn |
| Jun 30, 2023 | -89.18 Mn |
| Mar 31, 2023 | -123.33 Mn |
| Mar 31, 2023 | -123.33 Mn |
| Dec 31, 2022 | -70.30 Mn |
| Dec 31, 2022 | -70.30 Mn |
| Sep 30, 2022 | -43.56 Mn |
| Sep 30, 2022 | -43.56 Mn |
| Jun 30, 2022 | -81.31 Mn |
| Jun 30, 2022 | -81.31 Mn |
| Mar 31, 2022 | -61.34 Mn |
| Mar 31, 2022 | -61.34 Mn |
| Dec 31, 2021 | -24.14 Mn |
| Dec 31, 2021 | -24.14 Mn |
| Sep 30, 2021 | -33.73 Mn |
| Sep 30, 2021 | -33.73 Mn |
| Jun 30, 2021 | -29.26 Mn |
| Jun 30, 2021 | -29.26 Mn |
| Mar 31, 2021 | -27.02 Mn |
| Mar 31, 2021 | -27.02 Mn |
| Dec 31, 2020 | -37.91 Mn |
| Dec 31, 2020 | -37.91 Mn |
| Sep 30, 2020 | -24.32 Mn |
| Sep 30, 2020 | -24.32 Mn |